[Skip to Content]
[Skip to Content Landing]
May 2013

The Use of Aprepitant in Brachioradial Pruritus

Author Affiliations

Author Affiliations: Department of Dermatology, Stanford University School of Medicine, Stanford, California.

JAMA Dermatol. 2013;149(5):627-628. doi:10.1001/jamadermatol.2013.170

Brachioradial pruritus (BRP) is characterized by intractable itching localized to the dorsolateral aspects of the arms.1,2 Aprepitant (Emend; Merck & Co Inc), approved in 2003 for chemotherapy-induced nausea and vomiting, has been used successfully to treat patients with chronic pruritus,3,4 but to our knowledge, its use in BRP has not yet been reported.